Maternal serum irisin levels in normotensive and preeclamptic pregnancies: a systematic review and meta-analysis  

References

• Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia. Lancet. 2021;398(10297):341–354.
   PubMed Web of Science ®Google Scholar
• Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for preeclampsia: US preventive services task force recommendation statement. JAMA. 2017;317(16):1661–1667.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao Y, Yu A, et al. Diagnostic accuracy of the soluble fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a Meta-analysis based on 20 studies. Arch Gynecol Obstet. 2015;292(3):507–518.
   PubMed Web of Science ®Google Scholar
• He A, Zhou Y, Wei Y, et al. Potential protein biomarkers for preeclampsia. Cureus. 2020;12(6):e8925.
   PubMed Web of Science ®Google Scholar
• Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med. 2008;18(5):186–194.
   PubMed Web of Science ®Google Scholar
• D’Ippolito S, Tersigni C, Scambia G, et al. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors. 2012;38(1):14–23.
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–468.
   PubMed Web of Science ®Google Scholar
• Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8(4):e60563.
   PubMed Web of Science ®Google Scholar
• Castillo-Quan JI. From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity. Dis Model Mech. 2012;5(3):293–295.
   PubMed Web of Science ®Google Scholar
• Zhang W, Chang L, Zhang C, et al. Central and peripheral irisin differentially regulate blood pressure. Cardiovasc Drugs Ther. 2015;29(2):121–127.
   PubMed Web of Science ®Google Scholar
• Bi J, Zhang J, Ren Y, et al. Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage-related diseases. JCI Insight. 2020;5(13):e136277.
   PubMed Web of Science ®Google Scholar
• Farhan FS, Findakly SB, Sersam LW. Serum irisin levels in normotensive and preeclamptic pregnancies. Mustansiriya Med J. 2018;17(2):80–84.
   Google Scholar
• Foda AA, Foda EA. Effects of delivery on maternal & neonatal irisin levels in normal and preeclamptic pregnant women. Pregnancy Hypertens. 2017;10:226–229.
   PubMed Web of Science ®Google Scholar
• Garcés MF, Peralta JJ, Ruiz-Linares CE, et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia. J Clin Endocrinol Metab. 2014;99(6):2113–2119.
   PubMed Web of Science ®Google Scholar
• Kralisch-Jäcklein S, Richter J, Stephan H, et al. Serum levels of the myokine and adipokine irisin are decreased in pregnancies complicated by preeclampsia. Virtual meeting of European Association for the Study of Diabetes (Session: PS 109, ePoster 1267, Pregnancy: treatment, efficacy and safety). Barcelona 2013. Available from https://www.easd.org/
   Google Scholar
• Mansoor ZK, Saadoon WT, Abdulrasul EA. The association of serum level of irisin and urotensin II with insulin resistance in patients with preeclampsia. Biochem Cell Arch. 2020;20(2):5655–5660.
   Google Scholar
• Ozel A, Davutoglu EA, Firat A, et al. Maternal serum irisin levels in early and late-onset pre-eclamptic and healthy pregnancies. J Obstet Gynaecol. 2018;38(5):642–646.
   PubMedGoogle Scholar
• Yay T. Evaluation of serum adipomyokine levels in preeclamptic pregnant women/Evaluation of serum adipomyokine levels in preeclampsia. Supervisor: Pirimoğlu ZM. Thesis No: 464025. Dr. Lütfi Kırdar Kartal Training and Research Hospital, University of Health Sciences. Turkey. 2017. Available from https://tez.yok.gov.tr/UlusalTezMerkezi/tezDetay.jsp?id=q139NYAy4WEwM-fQcukLkA&no=5hq4dd1PIuivrexC6czgPA.
   Google Scholar
• Zhang LJ, Xie Q, Tang CS, et al. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia. Clin Exp Hypertens. 2017;39(5):460–467.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet. 2002;77(1):67–75.
   PubMed Web of Science ®Google Scholar
• Aydin S, Kuloglu T, Aydin S, et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides. 2014;61:130–136.
   PubMed Web of Science ®Google Scholar
• Lee P, Linderman JD, Smith S, et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014;19(2):302–309.
   PubMed Web of Science ®Google Scholar
• Du XL, Jiang WX, Lv ZT. Lower circulating irisin level in patients with diabetes mellitus: a systematic review and Meta-Analysis. Horm Metab Res. 2016;48(10):644–652.
   PubMed Web of Science ®Google Scholar
• Joung KE, Park KH, Filippaios A, et al. Cord blood irisin levels are positively correlated with birth weight in newborn infants. Metabolism. 2015;64(11):1507–1514.
   PubMed Web of Science ®Google Scholar
• Seppä S, Tenhola S, Voutilainen R. Fibroblast growth factor 21, adiponectin, and irisin as markers of unfavorable metabolic features in 12-Year-Old children. J Endocr Soc. 2019;3(4):825–837.
   PubMed Web of Science ®Google Scholar
• Pavlova T, Zlamal F, Tomandl J, et al. Irisin maternal plasma and cord blood levels in mothers with spontaneous preterm and term delivery. Dis Markers. 2018;2018:7628957.
   PubMed Web of Science ®Google Scholar
• Erol Koc EM, Çelik HK, Sahin D, et al. Maternal irisin level in last trimester isolated intrauterine growth-restriction. J Matern Fetal Neonatal Med. 2020;1–7.
   PubMedGoogle Scholar
• Çağlar M, Göksu M, Isenlik BS, et al. Irisin in idiopathic foetal growth restriction. J Endocrinol Invest. 2014;37(7):619–624.
   PubMed Web of Science ®Google Scholar
• Baka S, Malamitsi-Puchner A, Boutsikou T, et al. Cord blood irisin at the extremes of fetal growth. Metabolism. 2015;64(11):1515–1520.
   PubMed Web of Science ®Google Scholar
• Drewlo S, Johnson E, Kilburn BA, et al. Irisin induces trophoblast differentiation via AMPK activation in the human placenta. J Cell Physiol. 2020;235(10):7146–7158.
   PubMed Web of Science ®Google Scholar
• Kohan-Ghadr HR, Armistead B, Berg M, et al. Irisin protects the human placenta from oxidative stress and apoptosis via activation of the AKT signaling pathway. Int J Mol Sci. 2021;22(20):11229.
   PubMed Web of Science ®Google Scholar
• Alonso-Ventura V, Li Y, Pasupuleti V, et al. Effects of preeclampsia and eclampsia on maternal metabolic and biochemical outcomes in later life: a systematic review and Meta-analysis. Metabolism. 2020;102:154012.
   PubMed Web of Science ®Google Scholar
• Alonso-Ventura V, Pérez-López FR. Preeclampsia negatively affects future maternal metabolic and endocrine outcomes. Gynecol Endocrinol. 2021;37(9):773–774.
   PubMed Web of Science ®Google Scholar